Mersana Therapeutics Current Deferred Revenue (Per Share) Insights

Mersana Therapeutics, Inc. (DELISTED) (MRSN:DL)

29.08 0.00 (0.00%) USD | NASDAQ | Jan 15, 16:00

View Current Deferred Revenue (Per Share) for MRSN:DL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Per Share) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Per Share) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Per Share) Benchmarks

Start Trial

Cidara Therapeutics, Inc.	--
Day One Biopharmaceuticals, Inc.	Upgrade
Semler Scientific, Inc.	Upgrade
Cue Biopharma, Inc.	Upgrade
Scholar Rock Holding Corp.	--